This site is maintained for archival purposes only. New submissions, peer review, and editorial correspondence are handled through the new journal platform. Access the current journal site here.
Bulgarian Rheumatology Society recommendations for behavior during an epidemic with COVID-19
Vol. 28 No. 3 (2020), Editorial
Vol. 28 No. 3 (2020)

Bulgarian Rheumatology Society recommendations for behavior during an epidemic with COVID-19

Editorial
https://doi.org/10.35465/28.3.2020.pp3-6
Published November 16, 2020
Rumen Malinov Stoilov
Bulgaria
Vladimira Boyadzhieva
Clinic of Rheumatology, UMHAT "Sv. Ivan Rilski", Department of Rheumatology, Medical University - Sofia
Nikolay Stoilov
Clinic of Rheumatology, UMHAT "Sv. Ivan Rilski", Department of Rheumatology, Medical University - Sofia
Mariana Ivanova
Clinic of Rheumatology, UMHAT "Sv. Ivan Rilski", Department of Rheumatology, Medical University - Sofia
Anastas Batalov
Clinic of Rheumatology, University Hospital “Caspela”, Medical University – Plovdiv
Zlatimir Kolarov
Clinic of Rheumatology, UMHAT "Sv. Ivan Rilski", Department of Rheumatology, Medical University - Sofia
Simeon Monov
Clinic of Rheumatology, UMHAT "Sv. Ivan Rilski", Department of Rheumatology, Medical University - Sofia
Ivan Sheytanov
Clinic of Rheumatology, UMHAT "Sv. Ivan Rilski", Department of Rheumatology, Medical University - Sofia
PDF EN
PDF BG (Български)

Keywords

COVID-19

How to Cite

Stoilov, R., Boyadzhieva, V., Stoilov, N., Ivanova, M., Batalov, A., Kolarov, Z., Monov, S., & Sheytanov, I. (2020). Bulgarian Rheumatology Society recommendations for behavior during an epidemic with COVID-19. Rheumatology (Bulgaria), 28(3), 3-6. https://doi.org/10.35465/28.3.2020.pp3-6
ACM ACS APA ABNT Chicago Harvard IEEE MLA Turabian Vancouver

Download Citation

Endnote/Zotero/Mendeley (RIS) BibTeX
https://doi.org/10.35465/28.3.2020.pp3-6
PDF EN
PDF BG (Български)

References

    1. ACR guidance for patients during the Covid-19 outbreak. https://www.rheumatology.org/announcements. Accessed 29 Mar.2020.
    2. Askanase AD, Khalili L, Buyon JP. Thoughts on COVID-19 and autoimmune diseases. Lupus Sci Med. 2020 https ://doi.org/10.1136/lupus-2020-000396
    3. Australian Rheumatology Association guidance for patients during the Covid-19 outbreak. https ://arthritis australia.com.au/advice-regarding-coronavirus-covid-19-from-the-australian-rheumatology-association/ Accessed 19 Mar 2020.
    4. Boyadzhieva, VV., Stoilov, NR, Stoilov, RM. Coronavirus disease 2019 (COVID-19) during pregnancy in patients with rheumatic diseases. Rheumatol Int 2020;40, 1753-1762.
    5. BSR guidance for patients during the Covid-19 outbreak. https://www.rheumatology.org.uk/News-Policy/Details/Covid19Coronavirus-update-members Accessed 29 Mar 2020.
    6. Bin Chao. Chinese guidelines of diagnosis and treatment of COVID-19 (7th version). https ://www.sforl .org/wp-conte nt/uploads/2020/03/WUHAN-Exper ience.pdf Accessed 18 Mar 2020.
    7. Coronavirus (COVID-19) infection and pregnancy. Version 7 (2020) Guidance for healthcare professionals on coronavirus (COVID-19) infection in pregnancy, published by the RCOG,Royal College of Midwives, Royal College of Paediatrics and Child Health, Public Health England and Health Protection Scotland. https://www.rcog.org.uk/globalassets/documents/guidelines/2020-04-09-coronavirus-covid -19-infection-in-pregnancy. pdf Accessed: 9 Apr 2020.
    8. EULAR guidance for patients during the Covid-19 outbreak. https://www.eular.org/eularguidance_for_patients_covid 19_outbreak.cfm Accessed 19 Mar 2020
    9. Favre G, Pomar L, Qi X et al. Guidelines for pregnant women with suspected SARSCoV – infection. Lancet Infect Dis. 2020;(20)30157-2.
    10. Favalli E, Biggioggero M, Maioli G et al. Baricitinib for COVID-19: a suitable treatment? Lancet Infect Dis. 2020. https://doi.org/10.1016/S1473-3099(20)30262-0
    11. Huang C, Wang Y, Li X et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan China. Lancet 2020;395:497-506.
    12. Liu D, Li L, Wu X et al. Pregnancy and Perinatal Outcomes of Women with COVID-19 Pneumonia: A Preliminary Analysis. Available at SSRN: 2020. https://ssrn.com/abstract=3548758.
    13. Martinez-Portilla RJ, Gonce A, Hawkins – Villarreal A, Figueras F. A Spanish – translated clinical algorithm for management of suspected SARS-CoV-2 infection in pregnant women. Lancet Infect Dis. 2020. https ://doi.org/10.1016/S1473-3099(20)30285-1
    14. Mathian A, Mahevas M, Rohmer J et al. Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine. Ann Rheum Dis. 2020. https://doi.org/10.1136/annrheumdis-2020-21756 6
    15. Meselson M (2020) Droplets and aerosols in the transmission of SARS-CoV-2. N Engl J Med. https ://doi.org/10.1056/NEJMc20093 16
    16. Misra DP, Agarwal V, Gasparyan AY, Zimba O. Rheumatologists’ perspective on coronavirus disease 19 (COVID-19) and potential therapeutic targets. Clin Rheumatol 2020;39:2055-2062.
    17. National Psoriasis Foundation Medical Board COVID-19 Recommendations for patients with psoriatic disease. https://www.psoriasis.org/advance/coronavirus Accessed 10 Apr 2020.
    18. Practical guidance for the prevention of thrombosis and management of coagulopathy and disseminated intravascular coagulation of patients infected with COVID-19 (2020) https://thrombosisuk.org/covid-19-thrombosis.php Accessed 07 Apr 2020.
    19. Stebbing J, Phelan A, Griffin I et al. COVID-19: combining antiviral and anti-inflammatory treatments. Lancet Infect Dis 2020;20:400-402.
    20. The COVID-19 Global Rheumatology Alliance. https ://rheumcovid.org
    21. The COVID-19 Global Rheumatology Alliance Global Registry. https://mailchi.mp/a6dc80671481/just-launched-the-covid-19-global-rheumatology-registry-48107 62
    22. Tisoncik JR, Korth MJ, Simmons CP et al. Into the eye of the cytokine storm. Microbiol Mol Biology Rev Mmbr 2012;76:16-32.
    23. World Health Organization. Q&A on coronaviruses (COVID-19). https://www.who.int/news-room/q-a-detail/qcoronaviruses. Accessed: 17 Apr 2020.
    24. Wu Z, McCoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72,314 cases from the Chinese Center for Disease Control and Prevention. JAMA 2020;323(13):1239-1242.
    25. Yongwen L, Kai Y (2020) Management of pregnant women infected with COVID-19. Lancet Infect Dis. https ://doi.org/10.1016/S1473-3099(20)30191-2
    26. Yudin MH, Steele DM, Sgro MD et al. Severe acute respiratory syndrome in pregnancy. Obstet Gynecol 2005;105:124-127.
    27. Zhang W, Du R-H, Li B et al. Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes. Emerg Microbes Infect 2020;9:386-389.

Downloads

Download data is not yet available.